Roopen Arya
@AryaRoopen
Clinical Director for Haematology and Professor of Thrombosis & Haemostasis, King's College Hospital; Director, King’s Thrombosis Centre. Opinions are my own.
Is this the end of rivaroxaban for acute VTE? @LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025
Wonderful to participate in first #Space #Haematology session at a Haematology conference thanks to #EHA2025 ! Pleasure to share the stage with @joseph_borg_ & Judith-Irina Buchheim covering rbc, wbc and clotting changes in space. @EHA_Hematology @BritSocHaem @ASH_hematology
Very innovative for #EHA2025 to run a session on Space Haematology. @AryaRoopen very enlightening on the risks and potential treatment of VTE on a space station.
What can you expect in the first three months of recovery after a diagnosis of a blood clot? Check-out the video recording of Consultant Nurse Emma Gee discuss and answer FAQ on: 'Managing recovery in the first three months after a blood clot.' youtu.be/RdfILqvz88k?si…
The much used @RCObsGyn Greentop guideline 37a is being revised. Here is a @BJOGTweets commentary from @LauraAMagee1 and the guideline update committee. In the journal doi.org/10.1111/1471-0… and on video vimeo.com/1072760896
On our way to set up for Thrombosis UK's #VTEAwards! Today we celebrate achievement, innovation, service change and sheer hard work from individuals and teams to prevent, ensure prompt diagnosis & best management of #bloodclots. #safeguard improve #outcomes #recovery #lifesaving
Ready to join NTW'25 today? Delighted to welcome @AryaRoopen to our first session at 09:30 BST to discuss, 'Returning to everyday activity after a diagnosis of a blood clot' tuk-edu.vfairs.com
Day One at #NTW25 we welcome @bhwords & @AryaRoopen to chair 'How can we improve VTE risk assessment tools & compliance across UK?' with Dr C Bagot, Dr G Benson, Christine Welburn & Ethel Oldfield. Register & join - have your comments & questions ready! tuk-edu.vfairs.com/en/
📢@JTHjournal is proud to announce the recipients of the 2025 JTH Editors’ Awards! These prestigious awards honor 6 early career investigators for their top articles in thrombosis & hemostasis. Join us in congratulating the winners🎉 & learn more: bit.ly/4lc2pFR
Today, we have launched MaTRON, our UK-wide project looking at management of intermediate and high risk PE in pregnancy. This data is desperately needed to help plan services and future studies. There's still time to get involved tinyurl.com/22b3ucwp @GiuliaSimini1 @bhwords
We report 0.9% VTE within 90 days of hospital led acute ambulatory care attendance; similar to traditional medical inpatient care without thromprophylaxis. Further VTE research needed in this rapidly expanding area of medicine#VTE#SDEC @DanLasserson sciencedirect.com/science/articl…
We’re excited to launch the new enhanced sickle cell community service, providing holistic, community-based care for people of all ages in south east London. Learn more: selondonics.org/new-enhanced-s…
The 19th Annual @ascatconference in October focused on “Achieving Equitable Progress” in sickle cell & thalassaemia care. Highlights included: 🔬 Advancements in research & therapies 🤝 Tackling care inequalities 📈 Transformative projects More: slcn.nhs.uk/ascat/ #ASCAT2024
These studies can be challenging and we all need to learn from one another globally #Pharmacology2024 #AtTheEquatorUG pubmed.ncbi.nlm.nih.gov/39420408/
Next, Jig Patel draws from his experience studying oral anticoagulants in breastfeeding mothers who did not require the drug for their own health. Strong community engagement approach, and surprising finding: large difference between rivaroxaban and apixiban #Pharmacology2024
Science! Have you read the #PEERLESS trial comparing #thrombectomy (#LBMT) with #catheter-directed #thrombolysis (#CTD) for Intermediate-risk #pulmonary #embolism (#PE)? A critical read and analysis: 🧵1/5 ahajournals.org/doi/10.1161/CI…
Chimeric antigen receptor T cell therapy might revolutionize the management and our understanding of autoimmune diseases An short educational thread🧵on current status and future directions
Our wonderful team at Denmark Hill site in support of World Thrombosis day! #WTDay24 #WorldThrombosisDay #MoveAgainstThrombosis
The latest MBRRACE-UK Saving Lives, Improving Mothers’ Care report on women who died during or up to a year after pregnancy between 2020 and 2022 released today. Read more:buff.ly/2HR30eT @marianfknight @npeu_oxford @oxford_ndph